LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 26.51 | 84.90 | 1378 | 1923 | 0.7165 | 0.8573 | MN20160318_Q02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 26.51 | 84.90 | 1583 | 1923 | 0.8231 | 0.9154 | MN20160318_Q02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 26.51 | 84.90 | 1632 | 1923 | 0.8486 | 0.9284 | MN20160318_Q02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 26.51 | 84.90 | 56 | 1923 | 0.0291 | -0.0883 | MN20160318_Q02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 26.51 | 84.90 | 1402 | 1923 | 0.7290 | 0.8644 | MN20160318_Q02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 28.21 | 84.90 | 29 | 2091 | 0.0139 | -0.2073 | MN20160318_Q02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 28.21 | 84.90 | 1426 | 2091 | 0.6818 | 0.8410 | MN20160318_Q02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 28.21 | 84.90 | 1651 | 2091 | 0.7894 | 0.9003 | MN20160318_Q02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 28.21 | 84.90 | 1692 | 2091 | 0.8090 | 0.9104 | MN20160318_Q02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 28.21 | 84.90 | 95 | 2091 | 0.0454 | 0.0246 | MN20160318_Q02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 28.21 | 84.90 | 1464 | 2091 | 0.7000 | 0.8515 | MN20160318_Q02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 29.92 | 84.90 | 27 | 2237 | 0.0121 | -0.2155 | MN20160318_Q02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 29.92 | 84.90 | 1496 | 2237 | 0.6685 | 0.8365 | MN20160318_Q02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 29.92 | 84.90 | 1777 | 2237 | 0.7941 | 0.9047 | MN20160318_Q02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 29.92 | 84.90 | 1822 | 2237 | 0.8142 | 0.9148 | MN20160318_Q02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 29.92 | 84.90 | 90 | 2237 | 0.0402 | 0.0124 | MN20160318_Q02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 29.92 | 84.90 | 1549 | 2237 | 0.6922 | 0.8501 | MN20160318_Q02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 31.62 | 84.90 | 37 | 2449 | 0.0151 | -0.1574 | MN20160318_Q02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 31.62 | 84.90 | 1540 | 2449 | 0.6286 | 0.8175 | MN20160318_Q02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 31.62 | 84.90 | 1840 | 2449 | 0.7511 | 0.8854 | MN20160318_Q02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 31.62 | 84.90 | 1886 | 2449 | 0.7699 | 0.8950 | MN20160318_Q02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 31.62 | 84.90 | 102 | 2449 | 0.0416 | 0.0386 | MN20160318_Q02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 31.62 | 84.90 | 1720 | 2449 | 0.7021 | 0.8594 | MN20160318_Q02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 33.32 | 84.90 | 55 | 2722 | 0.0202 | -0.0831 | MN20160318_Q02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 33.32 | 84.90 | 1585 | 2722 | 0.5822 | 0.7950 | MN20160318_Q02 | G13 |